Hello from Fulton County, Ohio.

We had a recent near miss/good catch reported by a nurse who obtained a medication from an open matrix drawer in our Omnicell. When attempting to administer using barcoded medication administration, she realized it was the wrong medication, sucralfate instead of isosorbide mononitrate. Upon further investigation, there was more of the wrong medication in the wrong pocket- the 2 medications were stored directly adjacent to one another in the Omnicell open matrix drawer.

Does any site consent patients for medications derived from blood products (e.g., IVIG, Kcentra) to cover for the risk that the med may carry a risk of transmitting infectious agents, e.g., viruses. There is also the possibility that unknown infectious agents may be present in such products.

Appreciate your feedback.

Renu Bajwa, PharmD

At my hospital, currently enteral nutrition (tube feeding and supplements like Juven, Beneprotein, etc.) are not on the MAR and not BCMA'ed by nursing on administration. We are starting to explore with nursing and dietary how to start doing this.

Just curious how many others are doing this, and from a technical standpoint, how you have these orders built in your EHR? (We are on Epic). Do you have them built as ERX/medication records (to auto-verify) but so that they do appear on the MAR with due times, and require BCMA scan?

Recognizing the risk of Propofol-related infusion syndrome (PRIS) with propofol, we are looking to learn what safety measures health systems have implemented around the use of propofol. I would appreciate your responses to the following questions and any additional feedback:

Hello all,

Had a question for you guys. If not willing to discuss in the thread, I'd definitely be willing to schedule a discussion off line.

We are planning to open an ambulatory surgical center in the next 2 years. We are curious to know how like size (722 bed) academic medical centers with ambulatory surgical centers handle the compounding of hazardous medications at these locations. (i.e. – compound on site at ASC in hazardous cleanroom, or compound offsite and deliver to ASC).

Thanks!
Jameika

I'm wondering if anyone would like to share any policies they may have with respect to transportation of medications (controlled and/or non-controlled) to/from patients' homes. Examples might include OPAT programs or palliative care home care clients. Do you allow staff (pharmacists, nurses and/or unregulated healthcare professionals) to transport medications under any circumstances? Anything you could share would be very much appreciated.

Thanks
Rebecca Ellis
Home Care Pharmacist
Health PEI
Canada

Is anyone aware of any changes needed with the new "PS-Mycophenolate REMS program" approved 6/1/2023?

In comparison to the old REMS, the goals are the same and the prescriber form states "If you have previously completed the requirements of another Mycophenolate REMS, it is not necessary to complete the PS-Mycophenolate REMS.

I am a little confused as to why there is a second REMS program? Does not appear that the old one was removed or that providers need to resubmit a new prescriber training form. Maybe I am missing something?

Please help the GEDSA ENFit clinical advisory board assess conversion status by completing the following quick survey

https://forms.office.com/Pages/ResponsePage.aspx?id=WGRxUhS5HU61dYwQBPPs...

How does your institution calculate IBW for patients less than 5 feet tall?
How does your institution calculate IBW for patients with amputations
What formula do you currently use (growth charts, Traub formula, etc.)?

Interested in how other institutions have built their sterile water 10ml order sentences to reflect that it is for diluent use only. What route have you used in the orderable? I am thinking that we may need to build a new route of "diluent", "other" or "misc" for safety purposes to reflect that the SW itself should not be given IV Push without using as a diluent first. Appreciate any feedback.

Heather